Status: current, Primitive. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3722667016 | Elagolix sodium (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3722668014 | Elagolix sodium | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Elagolix sodium | Is modification of | Elagolix | true | Inferred relationship | Some | ||
| Elagolix sodium | Is a | Pyrimidine | true | Inferred relationship | Some | ||
| Elagolix sodium | Has disposition | Gonadotropin releasing hormone receptor antagonist | true | Inferred relationship | Some | ||
| Elagolix sodium | Is a | Gonadotropin releasing hormone receptor antagonist | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Elagolix sodium 300 mg oral capsule | Has BoSS | True | Elagolix sodium | Inferred relationship | Some | 1 |
| Elagolix sodium 300 mg oral capsule | Has precise active ingredient | True | Elagolix sodium | Inferred relationship | Some | 1 |
| Elagolix sodium 300 mg and estradiol 1 mg and norethisterone 500 microgram oral capsule | Has BoSS | True | Elagolix sodium | Inferred relationship | Some | 3 |
| Elagolix sodium 300 mg and estradiol 1 mg and norethisterone 500 microgram oral capsule | Has precise active ingredient | True | Elagolix sodium | Inferred relationship | Some | 3 |
Reference Sets
Substance foundation reference set
Australian dialect reference set
Description inactivation indicator reference set
FHIR